The marketing authorization holder has informed its supplied customers in a letter dated May 25, 2018, that a blister strip of another product from the same active ingredient group has been discovered in batch W28311 in a single package. As a precautionary measure, the affected batch is therefore being recalled due to this possible submixture.
|Name of the medicinal product
|Halcion 0,25 mg - Tabletten
|Marketing authorisation number(s)
|Marketing authorisation holder
|Pfizer Corporation Austria GmbH
|Classification of the recall
|BASG reference number